loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Alvelestat

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Alvelestat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat
    Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat

    17 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/17/2535304/0/en/Mereo-BioPharma-Receives-FDA-Fast-Track-Designation-for-Alvelestat-for-Treatment-of-Alpha-1-Antitrypsin-Deficiency-AATD-associated-Lung-Disease.html

    GLOBENEWSWIRE
    17 Oct 2022
    Share Share
    Mereo BioPharma’s Alvelestat Meets Endpoints in ASTRAEUS Trial in AATD
    Mereo BioPharma’s Alvelestat Meets Endpoints in ASTRAEUS Trial in AATD

    10 May 2022

    // TRIALSITENEWS

    https://www.trialsitenews.com/p/trialsitenews/mereo-biopharmas-alvelestat-meets-endpoints-in-astraeus-trial-in-patients-with-alpha-1-antitrypsin-deficiency-associated-emphysema-a1c221e1

    TRIALSITENEWS
    10 May 2022
    Share Share
    Mereo Announces Initiation of Placebo-Controlled Ph 1b/2 Trial with Alvelestat
    Mereo Announces Initiation of Placebo-Controlled Ph 1b/2 Trial with Alvelestat

    25 Aug 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/08/25/2083126/0/en/Mereo-BioPharma-Announces-Initiation-of-Placebo-Controlled-Phase-1b-2-Clinical-Trial-with-Alvelestat-in-COVID-19-Respiratory-Disease.html

    GLOBENEWSWIRE
    25 Aug 2020
    Share Share
    Celgene says no to Mereo’s cancer drug etigilimab
    Celgene says no to Mereo’s cancer drug etigilimab

    22 Jun 2019

    // Phil Taylor PM LIVE

    http://www.pmlive.com/pharma_news/celgene_says_no_to_mereos_cancer_drug_etigilimab_1291381

    Phil Taylor PM LIVE
    22 Jun 2019
    Share Share